$CHUC
Charlie's Holdings, Inc. Stock $chuc

$chuc Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000185173422000268 Filed on May 16, 2022

Income Statement

Concept	2022 Q1	2021 Q1	2021
Revenue	$8.074M	$4.361M	$4.361M
YoY Change	85.14%	-1.0%	-73.87%
Cost Of Revenue	$4.434M	$1.943M	$10.42M
YoY Change	128.2%	-1.02%	39.38%
Gross Profit	$3.640M	$2.418M	$11.07M
YoY Change	50.54%	-0.98%	20.18%
Gross Profit Margin	45.08%	55.45%	253.91%
Selling, General & Admin	$3.262M	$2.638M	$2.638M
YoY Change	23.65%	-42.28%	-79.07%
% of Gross Profit	89.62%	109.1%	23.82%
Research & Development	$11.00K	$9.000K	$9.000K
YoY Change	22.22%	-99.6%	-99.73%
% of Gross Profit	0.3%	0.37%	0.08%
Depreciation & Amortization	$67.00K	$50.00K	$210.0K
YoY Change	34.0%	25.0%	16.02%
% of Gross Profit	1.84%	2.07%	1.9%
Operating Expenses	$7.707M	$2.647M	$4.590M
YoY Change	191.16%	-61.03%	-80.44%
Operating Profit	$400.0K	-$229.0K	-$229.0K
YoY Change	-274.67%	-94.74%	-96.62%
Interest Expense	$1.000K	-$20.13M	$28.00K
YoY Change	-100.0%	-4781.4%	-79.1%
% of Operating Profit	0.25%
Other Income/Expense, Net	$339.0K	$5.000K	-$19.91M
YoY Change	6680.0%	0.0%	4674.1%
Pretax Income	$706.0K	-$20.14M	$5.150M
YoY Change	-103.51%	414.22%	-171.66%
Income Tax			$342.0K
% Of Pretax Income			6.64%
Net Earnings	$700.0K	-$20.14M	-$20.14M
YoY Change	-103.48%	414.22%	180.19%
Net Earnings / Revenue	8.67%	-461.75%	-461.75%
Basic Earnings Per Share	$0.00	-$0.10	-$0.10
Diluted Earnings Per Share	$0.00	-$0.10	-$0.10
COMMON SHARES
Basic Shares Outstanding	211.0M	195.1M	195.1M
Diluted Shares Outstanding	242.9M	195.1M	195.1M

Balance Sheet

Concept	2022 Q1	2021 Q1	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$409.0K	$3.455M	$866.0K
YoY Change	-88.16%	1382.83%	-39.1%
Cash & Equivalents	$409.0K	$3.455M
Short-Term Investments
Other Short-Term Assets	$1.226M	$354.0K	$755.0K
YoY Change	246.33%	-48.55%	67.78%
Inventory	$4.696M	$1.591M	$5.005M
Prepaid Expenses
Receivables	$1.717M	$1.081M	$1.368M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.000M	$6.481M	$7.994M
YoY Change	23.44%	56.7%	69.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$449.0K	$1.587M	$1.186M
YoY Change	-71.71%	-23.26%	-31.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$70.00K	$71.00K	$68.00K
YoY Change	-1.41%	0.0%	-4.23%
Total Long-Term Assets	$1.157M	$1.658M	$1.254M
YoY Change	-30.22%	-22.49%	-30.41%
TOTAL ASSETS
Total Short-Term Assets	$8.000M	$6.481M	$7.994M
Total Long-Term Assets	$1.157M	$1.658M	$1.254M
Total Assets	$9.205M	$8.139M	$9.248M
YoY Change	13.1%	29.71%	41.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.806M	$356.0K	$2.476M
YoY Change	407.3%	-89.01%	-1.94%
Accrued Expenses	$1.801M	$2.293M	$1.579M
YoY Change	-21.46%	421.14%	246.27%
Deferred Revenue	$316.0K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$4.800M	$29.20M	$5.534M
YoY Change	-83.56%	291.07%	-48.49%
LONG-TERM LIABILITIES
Long-Term Debt	$150.0K	$985.0K	$150.0K
YoY Change	-84.77%		-85.24%
Other Long-Term Liabilities	$376.0K	$641.0K	$433.0K
YoY Change	-41.34%	-41.89%	-43.18%
Total Long-Term Liabilities	$526.0K	$1.626M	$583.0K
YoY Change	-67.65%	47.42%	-67.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.800M	$29.20M	$5.534M
Total Long-Term Liabilities	$526.0K	$1.626M	$583.0K
Total Liabilities	$5.350M	$30.82M	$6.117M
YoY Change	-82.64%	259.7%	-51.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.149M
YoY Change
Common Stock	$217.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.855M	-$22.68M	$3.131M
YoY Change
Total Liabilities & Shareholders Equity	$9.205M	$8.139M	$9.248M
YoY Change	13.1%	29.71%	41.73%

Cashflow Statement

Concept	2022 Q1	2021 Q1	2021
OPERATING ACTIVITIES
Net Income	$700.0K	-$20.14M	-$20.14M
YoY Change	-103.48%	414.22%	180.19%
Depreciation, Depletion And Amortization	$67.00K	$50.00K	$210.0K
YoY Change	34.0%	25.0%	16.02%
Cash From Operating Activities	-$400.0K	$268.0K	-$1.347M
YoY Change	-249.25%	-112.34%	-58.85%
INVESTING ACTIVITIES
Capital Expenditures	$85.00K	$19.00K	$110.0K
YoY Change	347.37%	-144.19%	-34.91%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$85.00K	-$19.00K	-$110.0K
YoY Change	347.37%	-55.81%	-34.91%
FINANCING ACTIVITIES
Cash Dividend Paid			$883.0K
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$0.00	$1.784M	$901.0K
YoY Change	-100.0%		-62.71%
NET CHANGE
Cash From Operating Activities	-$400.0K	$268.0K	-$1.347M
Cash From Investing Activities	-$85.00K	-$19.00K	-$110.0K
Cash From Financing Activities	$0.00	$1.784M	$901.0K
Net Change In Cash	-$457.0K	$2.033M	-$556.0K
YoY Change	-122.48%	-191.78%	-45.81%
FREE CASH FLOW
Cash From Operating Activities	-$400.0K	$268.0K	-$1.347M
Capital Expenditures	$85.00K	$19.00K	$110.0K
Free Cash Flow	-$485.0K	$249.0K	-$1.457M
YoY Change	-294.78%	-111.7%	-57.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	216955520
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3684000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1800000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1800000
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	216840987
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	216840987
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	210890930
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	210890930
CY2019Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022Q1	us-gaap	Cash Cash	409000	USD
CY2021Q4	us-gaap	Cash Cash	866000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1717000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1368000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	4696000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	5005000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1226000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	755000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	8048000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	7994000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	449000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	431000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	638000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	755000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	70000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	68000	USD
CY2022Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1157000	USD
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1254000	USD
CY2022Q1	us-gaap	Assets Assets	9205000	USD
CY2021Q4	us-gaap	Assets Assets	9248000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4068000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	5350000	USD
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	583000	USD
CY2022Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	559000	USD
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	899000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	265000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	329000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	316000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	238000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4824000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5534000	USD
CY2022Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	150000	USD
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	150000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	376000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	433000	USD
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	526000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	6117000	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	217000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	211000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7787000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7775000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4149000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4855000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3855000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3131000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9205000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9248000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8074000	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4361000	USD
CY2022Q1	chuc	Cost Of Goods Sold Product Revenue CostOfGoodsSoldProductRevenue	4434000	USD
CY2021	chuc	Cost Of Goods Sold Product Revenue CostOfGoodsSoldProductRevenue	1943000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2559000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2218000	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	703000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	420000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	7707000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	4590000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	367000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-229000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	1000	USD
CY2021	us-gaap	Interest Expense InterestExpense	28000	USD
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	340000	USD
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-20102000	USD
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	217000	USD
CY2022Q1	us-gaap	Other Income OtherIncome	0	USD
CY2021	us-gaap	Other Income OtherIncome	5000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	339000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19908000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	706000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-20137000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-22684000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-20137000	USD
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	211007522
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	195141950
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	242854761
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	195141950
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3131000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	18000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	706000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3855000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-5996000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3000000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	90000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	359000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	706000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-20137000	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	97000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-12000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	67000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	50000	USD
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	340000	USD
CY2021Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-20102000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	117000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	113000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	18000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	359000	USD
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	USD
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	217000	USD
CY2022Q1	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-41000	USD
CY2021Q1	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	20395000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	446000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-189000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-309000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	471000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-96000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	2000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-0	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-384000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-336000	USD
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	78000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	174000	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-121000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-115000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-372000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	268000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	85000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-85000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	3000000	USD
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2021Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	184000	USD
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-0	USD
CY2021Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1400000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1784000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-457000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2033000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	866000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1422000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	409000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3455000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	150000	USD
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2022Q1	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2021Q1	us-gaap	Stock Issued1 StockIssued1	90000	USD
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	217000	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	400000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	700000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-400000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3900000	USD
CY2022Q1	chuc	Total Current Assets Excluding Cash TotalCurrentAssetsExcludingCash	7600000	USD
CY2021Q4	chuc	Total Current Assets Excluding Cash TotalCurrentAssetsExcludingCash	7100000	USD
CY2022Q1	us-gaap	Cash Cash	400000	USD
CY2021Q4	us-gaap	Cash Cash	900000	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Use of Estimates</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p>
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	899000	USD
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	340000	USD
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	559000	USD
CY2019Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	27500000	USD
CY2019Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.44313
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1189000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1104000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	740000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	673000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	449000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	431000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	67000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	50000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1806000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2476000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	896000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	902000	USD
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	342000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	342000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	640000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	348000	USD
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3684000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4068000	USD
CY2022Q1	chuc	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	150000	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	150000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	706000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20137000	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-0	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	366000	USD
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	340000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-20137000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	211007522
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	195141950
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	31847239
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	242854761
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	195141950
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	47201000
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	103484000
CY2020Q2	chuc	Share Exchange Value Per Share ShareExchangeValuePerShare	0.44313
CY2021Q2	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	1736501
CY2021Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.44313
CY2021Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.853
CY2021Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3000000.0	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7123000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.54
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	260000
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.44
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6863000
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.55
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y2M12D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	5283000
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.58
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	566000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	149000	USD
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	0	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	0	USD
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	566000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	149000	USD
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	USD
CY2021Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	USD
CY2022Q1	us-gaap	Lease Cost LeaseCost	566000	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	149000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	143000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	113000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M17D
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M24D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.120	pure
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.120	pure
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	256000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	275000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	206000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	737000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	96000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	641000	USD

Files In Submission

Name	View Source	Status
0001851734-22-000268-index-headers.html	Edgar Link	pending
0001851734-22-000268-index.html	Edgar Link	pending
0001851734-22-000268.txt	Edgar Link	pending
0001851734-22-000268-xbrl.zip	Edgar Link	pending
chuc-20220331.xsd	Edgar Link	pending
chuc-20220331_cal.xml	Edgar Link	unprocessable
chuc-20220331_def.xml	Edgar Link	unprocessable
chuc-20220331_lab.xml	Edgar Link	unprocessable
chuc-20220331_pre.xml	Edgar Link	unprocessable
chuc20220331_10q.htm	Edgar Link	pending
chuc20220331_10q_htm.xml	Edgar Link	completed
ex_370239.htm	Edgar Link	pending
ex_370240.htm	Edgar Link	pending
ex_370241.htm	Edgar Link	pending
ex_370242.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CHUC
Charlie's Holdings, Inc. Stock $chuc

2022 Q1 Form 10-Q Financial Statement

#000185173422000268 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHUC Charlie's Holdings, Inc. Stock $chuc

2022 Q1 Form 10-Q Financial Statement

#000185173422000268 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHUC
Charlie's Holdings, Inc. Stock $chuc